<DOC>
	<DOC>NCT02872311</DOC>
	<brief_summary>This is an open-label, randomized trial in up to 180 adults aged 65-74 years to evaluate the immune response to standard dose, high dose, and adjuvanted influenza vaccine across 2 seasons. Participants will be randomized to receive 1 of 3 licensed and recommended vaccines and will have pre and post-vaccination serum blood draws for a total of 6 draws over 18 months.</brief_summary>
	<brief_title>Open-Label Influenza Vaccine Evaluation</brief_title>
	<detailed_description />
	<mesh_term>Influenza, Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Age 6574 years at the time of study enrollment and are ambulatory and live in selected Wisconsin community or surrounding communities. Willing and able to give informed consent prior to study enrollment Able to comply with study requirements. Prior receipt of 201617 influenza vaccine Current participation in another clinical trial Presence of a contraindication to influenza vaccine</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Vaccine</keyword>
	<keyword>Influenza</keyword>
	<keyword>High Dose</keyword>
	<keyword>Adjuvanted</keyword>
</DOC>